Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_assertion description "[Patients who had progressed during or after first-line chemotherapy were prospectively assigned to EGFR-TKI treatment as follows: (G1) EGFR mutation (n = 12); (G2) highly polysomic/amplified EGFR (n = 18); (G3) EGFR and/or pAKT positive (n = 41); (G4) adenocarcinoma/bronchoalveolar carcinoma and no smoking history (n = 15).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_assertion evidence source_evidence_literature NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_assertion SIO_000772 22425916 NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_assertion wasDerivedFrom befree-2016 NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_assertion wasGeneratedBy ECO_0000203 NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.
- befree-2016 importedOn "2016-02-19" NP968341.RAm-CRKaG_wF61eACqilyJURHXp3vh7Ul_Ey0O_JLd2Eg130_provenance.